Skye is limitless

Unlocking the pharmaceutical potential of the endocannabinoid system

We are a pharmaceutical company developing proprietary molecules to treat diseases involving inflammatory, fibrotic, and metabolic conditions.

Our focus is on advancing first- and only-in-class drugs with potential to provide new therapeutic outcomes for diseases with significant prevalence and unmet needs.


Driven by science and results, we see the untapped opportunities ahead

Our team shares the experience, expertise, commitment, and passion for advancing our unique and proprietary molecules from discovery through commercialization.